Financial Performance - Net sales for Q3 2022 were 492.2million,a9.6449.1 million in Q3 2021[11]. - Gross profit for the nine months ended September 30, 2022, was 456.4million,slightlyupfrom455.8 million in the same period of 2021[11]. - Operating income decreased to 44.6millioninQ32022from36.0 million in Q3 2021, while for the nine months it was 105.9million,downfrom119.7 million[11]. - Net income attributable to Quaker Chemical Corporation for Q3 2022 was 25.9million,comparedto31.1 million in Q3 2021, reflecting a decline of 16.9%[11]. - For the nine months ended September 30, 2022, consolidated total revenue reached 1,458.8million,a10.91,314.1 million in the same period of 2021[54]. - Revenue from the Americas segment was 700.5million,up24.6562.8 million in the prior year[54]. - The Company reported total segment operating earnings of 108.951millionforthethreemonthsendedSeptember30,2022,comparedto95.374 million in Q3 2021, reflecting a 14.2% increase[44]. - The Company’s Global Specialty Businesses segment reported net sales of 101.094millionforQ32022,upfrom77.373 million in Q3 2021, marking a 30.5% increase[44]. - Basic earnings per common share for Q3 2022 was 1.44,downfrom1.74 in Q3 2021, representing a decrease of 17.3%[88]. - Non-GAAP earnings per diluted share for the third quarter of 2022 were 1.74,upfrom1.63 in the prior year quarter[136]. Cash Flow and Assets - Cash and cash equivalents decreased to 138.9millionasofSeptember30,2022,from165.2 million at the end of 2021[16]. - Total assets decreased to 2.83billionasofSeptember30,2022,from2.96 billion at the end of 2021[16]. - Cash flows from operating activities for the nine months ended September 30, 2022, resulted in a net cash used of 26.3million,comparedtoanetcashprovidedof2.5 million in the same period of 2021[19]. - The company experienced a net operating cash outflow of 26.3millioninthefirstninemonthsof2022,comparedtoanetoperatingcashflowof2.5 million in the same period of 2021[138]. - The Company had Amended Credit Facility borrowings outstanding of 941.2millionasofSeptember30,2022,comparedto889.6 million under the Original Credit Facility as of December 31, 2021[157]. Debt and Liabilities - Long-term debt increased to 931.5millionasofSeptember30,2022,comparedto836.4 million at the end of 2021[16]. - Total debt as of September 30, 2022, was 954.066million,anincreaseof5.9901.348 million as of December 31, 2021[97]. - The Company recorded a loss on extinguishment of debt amounting to 6.763millionduringtheninemonthsendedSeptember30,2022[77].−Thecumulativeliabilityforgrossunrecognizedtaxbenefitsdecreasedbyapproximately6.3 million from December 31, 2021, to 16.2millionasofSeptember30,2022[80].AcquisitionsandInvestments−InJanuary2022,thecompanyacquiredabusinessforapproximately8.0 million, enhancing its product offerings in the Americas region[28]. - In October 2022, Quaker Chemical Corporation acquired a business for approximately 3.5million,strengtheningitspositioninpicklinginhibitorsandadditives[26].−TheCompanyacquiredatin−platingsolutionsbusinessfor25.0 million, allocating 19.6milliontointangibleassetsandrecording5.0 million of goodwill[36]. - The acquisition of Baron Industries in November 2021 was valued at 11.0million,withpotentialearn−outprovisionstotalingupto4.5 million[31]. Operational Challenges - The company continues to face challenges from ongoing inflationary pressures, supply chain issues, and geopolitical factors, impacting its operations and market conditions[135]. - The decline in organic sales volumes was 9%, attributed to softer end market conditions, particularly in Europe and Asia/Pacific[135]. - The Company continues to monitor various financial, economic, and geopolitical conditions that could impact future performance, including the ongoing Russia-Ukraine war[92]. Tax and Regulatory Matters - The company's effective tax rates for the three and nine months ended September 30, 2022, were 28.1% and 19.2%, respectively, compared to 2.6% and 21.8% for the same periods in 2021[79]. - The company recognized a net benefit to the tax provision of 1.9millionduringthefirstninemonthsof2022duetothesettlementoftaxaudits[87].−TheCompanyexpectstoreduceitscumulativeliabilityforgrossunrecognizedtaxbenefitsbyapproximately4.1 million during the year ending December 31, 2022[83]. Strategic Initiatives - The QH Program aims to reduce total headcount by approximately 400 people globally, with ongoing reductions expected into 2023[59]. - The Company expects continued operating costs and cash flows related to strategic planning and transformation expenses in 2022 and extending into the next several years[159]. - The Company incurred strategic planning and transformation expenses of 4,545thousandinQ32022,comparedtonosuchexpensesinQ32021[174].Miscellaneous−TheCompanybelievesitsexistingcashandanticipatedcashflowswillbesufficienttosupportoperationsandfundbusinessobjectivesforatleastthenexttwelvemonths,includingongoingacquisitionintegrationandcapitalexpenditures[163].−TheCompanyrecorded10.4 million in total Combination, integration, and other acquisition-related expenses in the first nine months of 2022, down from $13.6 million in the same period of 2021[159].